Additional research is needed to ascertain the ideal circumstances for augmenting MIF action in the lung, potentially via the systemic or intra-pulmonary application of small molecule MIF modulators that would be protective of the developing lung predisposed to BPD. The gene discussed is MIF; the disease is bronchopulmonary dysplasia.